These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37625314)

  • 61. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
    Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW
    Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.
    Lambert JE; Ramos-Roman MA; Browning JD; Parks EJ
    Gastroenterology; 2014 Mar; 146(3):726-35. PubMed ID: 24316260
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
    Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
    J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hibiscus sabdariffa extract improves hepatic steatosis, partially through IRS-1/Akt and Nrf2 signaling pathways in rats fed a high fat diet.
    Prasomthong J; Limpeanchob N; Daodee S; Chonpathompikunlert P; Tunsophon S
    Sci Rep; 2022 Apr; 12(1):7022. PubMed ID: 35487948
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.
    Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM
    Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q?
    Cano A; Ciaffoni F; Safwat GM; Aspichueta P; Ochoa B; Bravo E; Botham KM
    J Appl Physiol (1985); 2009 Sep; 107(3):707-17. PubMed ID: 19608932
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress.
    Mosinski JD; Pagadala MR; Mulya A; Huang H; Dan O; Shimizu H; Batayyah E; Pai RK; Schauer PR; Brethauer SA; Kirwan JP
    Acta Physiol (Oxf); 2016 Jun; 217(2):141-51. PubMed ID: 26663034
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dissociation between rate of hepatic lipoprotein secretion and hepatocyte microtubule content.
    Reaven EP; Reaven GM
    J Cell Biol; 1978 Jun; 77(3):735-42. PubMed ID: 210192
    [TBL] [Abstract][Full Text] [Related]  

  • 69. GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice.
    Taher J; Baker C; Alvares D; Ijaz L; Hussain M; Adeli K
    Endocrinology; 2018 Sep; 159(9):3340-3350. PubMed ID: 30052880
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease.
    Magkos F; Fabbrini E; Korenblat K; Okunade AL; Patterson BW; Klein S
    Int J Obes (Lond); 2011 Sep; 35(9):1233-40. PubMed ID: 21179000
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
    Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
    Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].
    Zhong FW; Li GX; Zeng L
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2500-2508. PubMed ID: 35531697
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Characteristics of bile acid composition in high fat diet-induced nonalcoholic fatty liver disease in obese diabetic rats.
    Nakade Y; Kitano R; Sakamoto K; Kimoto S; Yamauchi T; Inoue T; Kobayashi Y; Ohashi T; Sumida Y; Ito K; Yoneda M
    PLoS One; 2021; 16(2):e0247303. PubMed ID: 33626072
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid.
    Forbes S; Godsland IF; Taylor-Robinson SD; Bell JD; Thomas EL; Patel N; Hamilton G; Parker KH; Marshall I; Gray CD; Bedford D; Caslake M; Walker BR; Johnston DG
    Diabetologia; 2013 Sep; 56(9):2021-33. PubMed ID: 23760677
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of a high-fat diet on rat very low density lipoprotein secretion.
    Kalopissis AD; Griglio S; Malewiak MI; Rozen R
    Biochim Biophys Acta; 1980 Oct; 620(1):111-9. PubMed ID: 7417475
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load.
    Gambino R; Bugianesi E; Rosso C; Mezzabotta L; Pinach S; Alemanno N; Saba F; Cassader M
    Int J Mol Sci; 2016 Mar; 17(4):479. PubMed ID: 27043543
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway.
    Fan L; Niu H; Zhao L; Yao R; He X; Lu B; Pang Z
    Biomed Pharmacother; 2022 Apr; 148():112697. PubMed ID: 35176709
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication.
    Israelsen M; Kim M; Suvitaival T; Madsen BS; Hansen CD; Torp N; Trost K; Thiele M; Hansen T; Legido-Quigley C; Krag A;
    JHEP Rep; 2021 Oct; 3(5):100325. PubMed ID: 34401690
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Associations of altered hepatic gene expression in American lifestyle-induced obesity syndrome diet-fed mice with metabolic changes during NAFLD development and progression.
    Iannone V; Lok J; Babu AF; Gómez-Gallego C; Willman RM; Koistinen VM; Klåvus A; Kettunen MI; Kårlund A; Schwab U; Hanhineva K; Kolehmainen M; El-Nezami H
    J Nutr Biochem; 2023 May; 115():109307. PubMed ID: 36868506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.